Financials 3/01/2010-2/28/2011


ASSETS Cash and


Cash Equivalents


Accounts, Grants, and Pledges Receivable


Prepaid Expenses and Other Assets


Property and Equipment, Net


Investments TOTAL Assets


14,649,264 254,398 270,773 5,481,233 $27,871,366 14,381,394 164,838 567,555 5,397,635 $27,760,689


Grants and Contracts Investment Income* Special Events Donated Public Service Advertising Contributions


*Dividends and Interest + Investment Gains


2011 $7,215,698


2010 1% $7,249,267 FY2011 TOTAL FUNDS $67,628,007 3% 3% 3% 3% 11% 11%


82%


1% 1%


LIABILITIES AND NET ASSETS


Accounts Payable Accrued Expenses Deferred Revenue Total Liabilities Net Assets


TOTAL Liabilities and Net Assets


2% 2011


$13,981,242 1,080,835 2,006,179 17,068,256 10,803,110 $27,871,366


2010


$14,419,907 961,207


1,674,797 17,055,911 10,704,778 $27,760,689


FY2011 TOTAL EXPENSES $67,529,675


PROGRAM EXPENSES Clinical and Lab Research Communications and Public Policy Donated Public Service Advertising Biostatistics and Data Mgmt Clinical Research Operations


SUPPORT SERVICES Administration Fundraising


2%


3% 3% 3%


3% 9% 9%


16% 66% 66%


16%


2011 ANNUAL REPORT 23


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28